BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26896959)

  • 1. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.
    Ruan J; Zheng H; Fu W; Zhao P; Su N; Luo R
    PLoS One; 2014; 9(11):e112136. PubMed ID: 25384089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.
    Lei T; Ling X
    World J Gastroenterol; 2015 Sep; 21(35):10137-49. PubMed ID: 26401078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Yang F; Lv L; Zhang K; Cai Q; Liu J; Jiang Y
    Cell Physiol Biochem; 2017; 44(1):99-109. PubMed ID: 29131008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PES1 enhances proliferation and tumorigenesis in hepatocellular carcinoma via the PI3K/AKT pathway.
    Wang J; Sun J; Zhang N; Yang R; Li H; Zhang Y; Chen K; Kong D
    Life Sci; 2019 Feb; 219():182-189. PubMed ID: 30630006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.
    Shi GM; Ke AW; Zhou J; Wang XY; Xu Y; Ding ZB; Devbhandari RP; Huang XY; Qiu SJ; Shi YH; Dai Z; Yang XR; Yang GH; Fan J
    Hepatology; 2010 Jul; 52(1):183-96. PubMed ID: 20578262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
    Wang H; Ma D; Wang C; Zhao S; Liu C
    Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
    Liu Z; Chen M; Xie LK; Liu T; Zou ZW; Li Y; Chen P; Peng X; Ma C; Zhang WJ; Li PD
    Aging (Albany NY); 2018 Oct; 10(10):2570-2584. PubMed ID: 30312171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
    Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
    J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway.
    Tang Y; Lv P; Sun Z; Han L; Zhou W
    PLoS One; 2016; 11(1):e0146070. PubMed ID: 26730736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.
    Wang JH; Wei W; Guo ZX; Shi M; Guo RP
    J Transl Med; 2015 Feb; 13():41. PubMed ID: 25638165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.